View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Nikola Kalanoski ... (+2)
  • Nikola Kalanoski
  • Simon Jönsson

Precise Biometrics - Highlighting US potential

Sales and EBITDA below ABGSCe in Q3 Digital Identity up-and-coming, Algo hit by macro Share trades at ’23e-’24e EV/sales of 2.6x-2.0x

Nikola Kalanoski ... (+2)
  • Nikola Kalanoski
  • Simon Jönsson

Precise Biometrics - Q3 softened by weak mobile phone demand

Sales SEK 18.8m, -35% vs. ABGSCe SEK 28.9m EBITDA SEK -1.8m vs. ABGSCe SEK 3.8m We anticipate negative consensus est. revisions

Nikola Kalanoski ... (+2)
  • Nikola Kalanoski
  • Simon Jönsson

Precise Biometrics - All eyes on commercialisation

Q3 report due Friday, 11 November We reduce ’23e-’24e sales by 3-1% Balance sheet set for growth after share issues

Simon Jönsson
  • Simon Jönsson

Precise Biometrics - Hit by a weaker smartphone market

Sales and EBITDA below ABGSCe in Q2 Raises up to SEK 83m in a rights issue Share trades at 3.4x-2.6x EV/sales on ‘22e-‘24e

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - New contracts will continue to drive metrics

Sales and EBITDA beat in Q1 New contracts agreed and we expect more going forward Trades at 3.5x-2.9x ’22-’23e EV/sales, 5Y NTM avg. 3.1x

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - 39% sales growth and EBITDA beat

Sales +39% y-o-y, +12% vs. ABGSCe EBITDA SEK 4.0m +44% vs. ABGSCe SEK 2.8m We expect consensus to slightly come up

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - More to come in 2022

Q4: sales +22%, EBITDA SEK 1.7m (vs 0.7m in Q4’20) Sales CAGR of 25% for ’21-24e Share trading at EV/sales of 4.1x-3.6x for ’22e-’23e

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - 22% sales growth, especially strong in DI

Sales +22% y-o-y, -16% vs. ABGSCe Pilot project with EastCoast planned to launch in H1’22 Trading at ’22e EV/sales of 3.6x on unrevised estimates

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - Stars aligned to deliver a strong 2022

Q4 results due on 18 February We expect sales of SEK 33m and EBITDA of SEK 2m Share trading at EV/sales of 3.5-3.1 for ’22e-’23e

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - The Algo journey continues

Signs license agreements – SEK 9m in upfront payment Will likely generate additional revenues Trading at 2.4x ‘22 EV/Sales on current estimates

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - Acquisitions make profitability reachable

Acquires EastCoast Solutions for SEK 80m, 27x EBITDA Has an EBITDA margin of 17% vs Precises 1% LTM Conf call 30 November 2021 at 10.00 CET

Rebecka Gärderup ... (+2)
  • Rebecka Gärderup
  • Simon Jönsson

Precise Biometrics - Customer activity starting to increase

Q3 Sales -27% y-o-y and EBITDA SEK 1m, -10% y-o-y Lower GM due to less profitable product mix The share trades at EV/sales of 3.63x-3.07x for ’22e-’23e

Jesper Birch-Jensen
  • Jesper Birch-Jensen

Precise Biometrics - Short-term component shortage pressure

Q2 EBITDA of SEK -0.8m vs. ABGSCe SEK -0.4m Lower growth assumptions on component shortage Adjust DCF fair value range to SEK 0.72-2.60 per share

Jesper Birch-Jensen
  • Jesper Birch-Jensen

Precise Biometrics - No surprises in Q1’21 for Precise

Q1’21 EBITDA SEK 0m vs. ABGSCe SEK 0m Estimates intact but cost composition adjusted Adjust DCF fair value to SEK 0.76-2.77 (0.72-2.75)

Jesper Birch-Jensen
  • Jesper Birch-Jensen

Precise Biometrics - Uncertain growth prospects in ’21e

Q4 EBITDA SEK 1m vs. ABGSCe SEK 4m We expect flat growth ’21e on Mobile uncertainty DCF fair value SEK 0.72-2.75 (0.84-2.82) per share

Jesper Birch-Jensen
  • Jesper Birch-Jensen

Precise Biometrics - Solid Q4, ’21e features continued roll-outs

Q4 EBITDA SEK 1m vs. ABGSCe SEK 4m ‘21e to see continued investments in YOUNiQ Conference call at 10:00 CET

Jesper Birch-Jensen
  • Jesper Birch-Jensen

Precise Biometrics - Unfavourable mix in Q3, but YOUNIQ impresses

Q3 EBIT of SEK -2m as unfavourable mix hit margins Estimate revisions driven by the Q3 report DCF fair value range SEK 0.84-2.82 (0.84-2.86)

Jesper Birch-Jensen
  • Jesper Birch-Jensen

Precise Biometrics - ESG profile

Precise’s vision is to enable convenient and secure identification. By fostering innovation, the company contributes to society's development and by securing identification, the company contributes to people's safety. On the other hand, there are risks involved, as identification is a sensitive matter in most situations. The company cooperates with several partners, and given technology complexities, there is a risk of not being able to assess stakeholders' governance. ESG profile

Jesper Birch-Jensen
  • Jesper Birch-Jensen

Precise Biometrics - Strong performance despite COVID-19 worries

Q2’20 EBITDA SEK 2m, +197.9% vs. ABGSCe Continued commercialisation of Precise YOUNIQ DCF fair value of SEK 0.84-2.86, ‘20e EV/

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch